A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
February 16th, 2018
7.2K views
Dormant and active cancer cell phenotypes were characterized using quantitative phase imaging. Cell proliferation, migration, and morphology assays were integrated and analyzed in one simple method.
Overview
This study quantitatively characterizes angiogenic and non-angiogenic phenotypes of human osteosarcoma cells using a systematic approach. The integrated method analyzes cell morphology, proliferation, and motility to provide insights into cancer progression.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cancer Research
Background
- Understanding cancer cell behavior is crucial for developing effective treatments.
- Cell dormancy and the transition to active states are key factors in tumor progression.
- Quantitative phase imaging allows for detailed analysis of cell characteristics.
- Simultaneous analysis of multiple parameters enhances research efficiency.
Purpose of Study
- To characterize the differences between dormant and active cancer cell phenotypes.
- To investigate the mechanisms behind tumor dormancy and escape.
- To provide a comprehensive method for analyzing cancer cell behavior.
Methods Used
- Quantitative phase imaging for cell characterization.
- Assays for cell proliferation and migration.
- Analysis of cell morphology including area, thickness, and volume.
- Integration of multiple assays into a single method for efficiency.
Main Results
- Identification of distinct phenotypes based on angiogenic properties.
- Quantitative data on cell proliferation rates and motility.
- Insights into the transition from dormancy to active proliferation.
- Demonstration of the effectiveness of the integrated analysis method.
Conclusions
- The study provides a novel approach to understanding cancer cell dynamics.
- Findings may inform future cancer treatment strategies.
- Integrated methods can enhance the efficiency of cancer research.
Frequently Asked Questions
What is the significance of studying cancer cell phenotypes?
Studying cancer cell phenotypes helps understand tumor behavior and progression, which is crucial for developing effective therapies.
How does quantitative phase imaging work?
Quantitative phase imaging measures the optical properties of cells, allowing for detailed analysis of their morphology and behavior.
What are the main parameters analyzed in this study?
The study analyzes cell area, thickness, volume, proliferation rate, and motility speed.
Why is it important to analyze multiple parameters simultaneously?
Simultaneous analysis provides a comprehensive view of cell behavior, improving the understanding of complex biological processes.
What implications do the findings have for cancer treatment?
The findings may lead to new strategies for targeting dormant cancer cells and preventing tumor recurrence.
Executive Industry Relevance
Quantitative phase imaging enables label-free, time-resolved analysis of cancer cell phenotypes, supporting mechanistic de-risking in target validation by quantifying morphological and behavioral shifts associated with angiogenic switching. This approach provides predictive confidence in distinguishing dormant and active states, informing early discovery decisions about therapeutic intervention points in tumor progression.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying angiogenic and non-angiogenic phenotypes in human cancer cells.
- Operational Value: Supports biological de-risking through label-free, longitudinal tracking of proliferation and motility parameters.
- Predictive Value: Facilitates portfolio triage by identifying phenotypic signatures linked to tumor dormancy escape.
Screening & Assay Development
- Assay Readiness: Generates standardized, quantitative outputs for cell area, thickness, volume, proliferation rate, and motility speed.
- Reproducibility: Enables consistent measurement across conditions via automated image acquisition and analysis workflows.
- Scalability: Supports multiplexed parameter analysis in a single platform, reducing need for multiple orthogonal assays.
Translational & Preclinical Research
- Translational Continuity: Connects in vitro phenotypic analysis to in vivo relevance of angiogenic switching in tumor dormancy escape.
- Mechanistic De-risking: Provides quantitative biomarkers (e.g., cell thickness, motility) to assess progression risk in preclinical models.
- Predictive Confidence: Enables data-driven go/no-go decisions by linking morphological changes to functional angiogenic potential.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by delivering multiparametric phenotypic data that informs target validation and lead identification stages through continuous, non-invasive monitoring.
- Discovery Biology: Supports hypothesis testing of angiogenic switching by quantifying concurrent changes in morphology, proliferation, and motility.
- Screening: Delivers assay-ready, quantitative readouts enabling comparison of compound effects on cancer cell phenotypes.
- Analytics: Provides normalized proliferation rates and doubling time calculations from time-lapse data for comparative condition analysis.
- Translational Research: Aligns with preclinical validation by establishing disease-relevant phenotypic benchmarks for osteosarcoma models.
- Enterprise Reuse: Functions as a reusable imaging platform applicable across cancer types and phenotypic screening campaigns.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in cancer cell behavior through direct, label-free quantification of angiogenic phenotypes.
- Operational Value: Standardizes multiparametric analysis via integrated imaging, minimizing reagent use and technical variability.
- Strategic Value: Improves capital efficiency by consolidating morphology, proliferation, and motility assays into one workflow.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on quantitative phenotypic dormancy-escape signatures.
Implementation Considerations
- Requires expertise in quantitative phase imaging instrumentation and software-based morphometric analysis.
- Dependent on stable environmental control (temperature, CO2) for 48-hour time-lapse imaging fidelity.
- Necessitates standardized cell seeding and preparation protocols to ensure phenotypic consistency across wells.
- Involves manual validation steps for cell segmentation and tracking to maintain data integrity.
- Limited by field of view and throughput constraints inherent to single-position time-lapse acquisition.
Biopharma FAQs
Why does quantitative phase imaging measurement of cell thickness matter for target validation?
Quantitative phase imaging measures cell thickness via refractive index and optical path length, providing a label-free metric to distinguish angiogenic from non-angiogenic phenotypes. This parameter revealed distinct distribution patterns between cell types, supporting phenotypic discrimination in target validation workflows.
How does isolation of proliferation rate as a dependent variable fit the cancer discovery pipeline?
Proliferation rate is derived by normalizing cell counts to initial numbers and plotting over time, enabling exponential growth curve fitting for doubling time estimation. This quantitative output allows direct comparison of angiogenic and non-angiogenic states in early discovery assays.
What does simultaneous measurement of motility speed and migration enable in phenotypic screening?
Motility speed, migration, and directness are tracked by selecting and following individual cells over time, with trajectory plots generated from time-lapse data. Simultaneous capture of these motion parameters supports comprehensive behavioral profiling in screening campaigns.
Why do replication requirements across imaging intervals matter for cross-functional collaboration?
The protocol requires image acquisition at intervals shorter than five minutes over a 48-hour period to capture dynamic phenotypic changes. Consistent replication ensures reliable tracking and analysis, enabling shared data interpretation between biology and analytics teams.
What statistical analysis capabilities are required before implementing quantitative phase imaging for phenotypic comparison?
Implementation requires capability to normalize cell counts, fit exponential growth curves for doubling time, and generate scatter plots or histograms for morphological parameters. These analytical functions are integrated into the software for post-acquisition data processing and export.
Chapters in this video
0:04
Title
0:58
Cell Preparation
2:35
Cell Preparation: Splitting KHOS-A and KHOS-N Cells
3:50
Cell Preparation: Seeding KHOS-A and KHOS-N Cells for QPI
4:30
Quantitative Phase Image Acquisition: Cover Slip Set-up
5:19
Quantitative Phase Imaging
7:03
Analyzing Cell Morphology
8:20
Analyzing Cell Proliferation
8:54
Analyzing Cell Motion
10:16
Results: Quantiative Phase Imaging of Dormant and Active Human Cancer Cells
11:50
Conclusion
